Leerink Partners Cuts Price Target on Amicus Therapeutics (FOLD) Following FDA Feedback

Go back to Leerink Partners Cuts Price Target on Amicus Therapeutics (FOLD) Following FDA Feedback
Amicus Therapeutics, Inc. (NASDAQ: FOLD) Delayed: 14.49 --0 (-0%)
Previous Close $14.49    52 Week High $11.78 
Open $14.49    52 Week Low $4.98 
Day High $14.49    P/E N/A 
Day Low $14.49    EPS $-1.15 
Volume 93,000